125 Broadway Update 09/19/22

Biogen Building 8 Sold for $600+ Million in Cambridge

Biogen Realty Limited Partnership has sold 125 Broadway in Cambridge to for $602,840,000. 

In conjunction with the acquisition of 125 Broadway, BXP and Biogen terminated their existing lease agreement at 300 Binney Street, an adjacent six-story, 195,000 square foot property developed by BXP in 2013, to facilitate the conversion and expansion of the property to 240,000 square feet of laboratory/life sciences space. BXP also announced that it signed a 15-year lease with a prominent life sciences organization. The lease is expected to commence upon completion of the renovations in late 2024.

“We are thrilled to complete this acquisition and continue our longstanding relationship with Biogen,” said Bryan Koop, Executive Vice President, Boston Region, of BXP. “BXP has been an integral member of the Cambridge community since the development of our first property in 1981, and we are pleased to continue to grow and evolve Kendall Center to meet the needs of the life sciences community.”

A 6-story lab/office asset located off Galileo Galilei Way in Cambridge's Kendall Square, 125 Broadway features square-feet of Class-B lab/research floorspace.

View 125 Broadway >>

Search BLDUP

Search BLDUP for news, projects, and companies to find the information that pushes your business forward.

Related News